{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:13:10Z","timestamp":1792714390001,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10157-025-02707-7","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T04:32:29Z","timestamp":1750134749000},"page":"1331-1341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Resveratrol glycoside inhibits NLRP3\/IL-1\u03b2\/NF-\u03baB to alleviate peritoneal fibrosis in peritoneal dialysis"],"prefix":"10.1007","volume":"29","author":[{"given":"Kanghan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuhao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaxi","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"2707_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23094831","author":"V Masola","year":"2022","unstructured":"Masola V, Bonomini M, Borrelli S, et al. Fibrosis of peritoneal membrane as target of new therapies in peritoneal dialysis. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23094831.","journal-title":"Int J Mol Sci"},{"key":"2707_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109778","volume":"75","author":"MS Balzer","year":"2020","unstructured":"Balzer MS. Molecular pathways in peritoneal fibrosis. Cell Signal. 2020;75: 109778. https:\/\/doi.org\/10.1016\/j.cellsig.2020.109778.","journal-title":"Cell Signal"},{"issue":"3","key":"2707_CR3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.kint.2016.03.040","volume":"90","author":"Q Zhou","year":"2016","unstructured":"Zhou Q, Bajo MA, Del Peso G, Yu X, Selgas R. Preventing peritoneal membrane fibrosis in peritoneal dialysis patients. Kidney Int. 2016;90(3):515\u201324. https:\/\/doi.org\/10.1016\/j.kint.2016.03.040.","journal-title":"Kidney Int"},{"issue":"9","key":"2707_CR4","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1681\/asn.2015030299","volume":"27","author":"L Wang","year":"2016","unstructured":"Wang L, Liu N, Xiong C, et al. Inhibition of EGF receptor blocks the development and progression of peritoneal fibrosis. J Am Soc Nephrol. 2016;27(9):2631\u201344. https:\/\/doi.org\/10.1681\/asn.2015030299.","journal-title":"J Am Soc Nephrol"},{"key":"2707_CR5","doi-asserted-by":"publisher","first-page":"114326","DOI":"10.1016\/j.bbr.2023.114326","volume":"443","author":"Y Yin","year":"2023","unstructured":"Yin Y, Lv G, Zhang W, et al. Resveratrol glycoside mediates microglial endoplasmic reticulum stress to mitigate LPS-induced sepsis-associated cognitive dysfunction. Behav Brain Res. 2023;443:114326. https:\/\/doi.org\/10.1016\/j.bbr.2023.114326.","journal-title":"Behav Brain Res"},{"key":"2707_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.857879","volume":"9","author":"G Zhao","year":"2022","unstructured":"Zhao G, Yang L, Zhong W, et al. Polydatin, a glycoside of resveratrol, is better than resveratrol in alleviating non-alcoholic fatty liver disease in mice fed a high-fructose diet. Front Nutr. 2022;9: 857879. https:\/\/doi.org\/10.3389\/fnut.2022.857879.","journal-title":"Front Nutr"},{"key":"2707_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11112888","author":"R G\u00e1l","year":"2023","unstructured":"G\u00e1l R, Halmosi R, Gallyas F Jr, et al. Resveratrol and beyond: the effect of natural polyphenols on the cardiovascular system: a narrative review. Biomedicines. 2023. https:\/\/doi.org\/10.3390\/biomedicines11112888.","journal-title":"Biomedicines"},{"key":"2707_CR8","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.ijbiomac.2014.08.031","volume":"72","author":"BA Rocha","year":"2015","unstructured":"Rocha BA, Teixeira CS, Silva-Filho JC, et al. Structural basis of ConM binding with resveratrol, an anti-inflammatory and antioxidant polyphenol. Int J Biol Macromol. 2015;72:1136\u201342. https:\/\/doi.org\/10.1016\/j.ijbiomac.2014.08.031.","journal-title":"Int J Biol Macromol"},{"key":"2707_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13765-021-00607-4","author":"Y Chong","year":"2021","unstructured":"Chong Y, Lee HL, Song J, et al. Biosynthesis of resveratrol derivatives and evaluation of their anti-inflammatory activity. Appl Biol Chem. 2021. https:\/\/doi.org\/10.1186\/s13765-021-00607-4.","journal-title":"Appl Biol Chem"},{"key":"2707_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133328","author":"N Kelley","year":"2019","unstructured":"Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20133328.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2707_CR11","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41590-021-00886-5","volume":"22","author":"BR Sharma","year":"2021","unstructured":"Sharma BR, Kanneganti TD. NLRP3 inflammasome in cancer and metabolic diseases. Nat Immunol. 2021;22(5):550\u20139. https:\/\/doi.org\/10.1038\/s41590-021-00886-5.","journal-title":"Nat Immunol"},{"key":"2707_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101638","volume":"79","author":"Y Liu","year":"2022","unstructured":"Liu Y, Xu X, Lei W, et al. The NLRP3 inflammasome in fibrosis and aging: the known unknowns. Ageing Res Rev. 2022;79: 101638. https:\/\/doi.org\/10.1016\/j.arr.2022.101638.","journal-title":"Ageing Res Rev"},{"key":"2707_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/biom12050634","author":"CM Artlett","year":"2022","unstructured":"Artlett CM. The mechanism and regulation of the NLRP3 inflammasome during fibrosis. Biomolecules. 2022. https:\/\/doi.org\/10.3390\/biom12050634.","journal-title":"Biomolecules"},{"issue":"12","key":"2707_CR14","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1038\/s41401-020-0475-6","volume":"41","author":"ZQ Chen","year":"2020","unstructured":"Chen ZQ, Sun XH, Li XJ, et al. Polydatin attenuates renal fibrosis in diabetic mice through regulating the Cx32-Nox4 signaling pathway. Acta Pharmacol Sin. 2020;41(12):1587\u201396. https:\/\/doi.org\/10.1038\/s41401-020-0475-6.","journal-title":"Acta Pharmacol Sin"},{"key":"2707_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.607204","volume":"12","author":"M Terri","year":"2021","unstructured":"Terri M, Trionfetti F, Montaldo C, et al. Mechanisms of peritoneal fibrosis: focus on immune cells-peritoneal stroma interactions. Front Immunol. 2021;12: 607204. https:\/\/doi.org\/10.3389\/fimmu.2021.607204.","journal-title":"Front Immunol"},{"key":"2707_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/134708","volume":"2015","author":"J Witowski","year":"2015","unstructured":"Witowski J, Kawka E, Rudolf A, J\u00f6rres A. New developments in peritoneal fibroblast biology: implications for inflammation and fibrosis in peritoneal dialysis. Biomed Res Int. 2015;2015: 134708. https:\/\/doi.org\/10.1155\/2015\/134708.","journal-title":"Biomed Res Int"},{"key":"2707_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.phymed.2018.12.024","volume":"57","author":"S Liu","year":"2019","unstructured":"Liu S, Zhao M, Zhou Y, et al. Resveratrol exerts dose-dependent anti-fibrotic or pro-fibrotic effects in kidneys: a potential risk to individuals with impaired kidney function. Phytomedicine. 2019;57:223\u201335. https:\/\/doi.org\/10.1016\/j.phymed.2018.12.024.","journal-title":"Phytomedicine"},{"issue":"24","key":"2707_CR18","doi-asserted-by":"publisher","first-page":"4745","DOI":"10.1111\/bph.14842","volume":"176","author":"X Zhang","year":"2019","unstructured":"Zhang X, Lu H, Xie S, et al. Resveratrol suppresses the myofibroblastic phenotype and fibrosis formation in kidneys via proliferation-related signalling pathways. Br J Pharmacol. 2019;176(24):4745\u201359. https:\/\/doi.org\/10.1111\/bph.14842.","journal-title":"Br J Pharmacol"},{"key":"2707_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.biopha.2018.05.104","volume":"105","author":"J Wang","year":"2018","unstructured":"Wang J, He F, Chen L, et al. Resveratrol inhibits pulmonary fibrosis by regulating miR-21 through MAPK\/AP-1 pathways. Biomed Pharmacother. 2018;105:37\u201344. https:\/\/doi.org\/10.1016\/j.biopha.2018.05.104.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"2707_CR20","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1007\/s10753-021-01586-w","volume":"45","author":"Z Ma","year":"2022","unstructured":"Ma Z, Sheng L, Li J, et al. Resveratrol alleviates hepatic fibrosis in associated with decreased endoplasmic reticulum stress-mediated apoptosis and inflammation. Inflammation. 2022;45(2):812\u201323. https:\/\/doi.org\/10.1007\/s10753-021-01586-w.","journal-title":"Inflammation"},{"issue":"11","key":"2707_CR21","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1111\/jcmm.12898","volume":"20","author":"C Song","year":"2016","unstructured":"Song C, He L, Zhang J, et al. Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL-1\u03b2\/IL-1R1\/MyD88\/NF-\u03baB pathway. J Cell Mol Med. 2016;20(11):2064\u201377. https:\/\/doi.org\/10.1111\/jcmm.12898.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"2707_CR22","doi-asserted-by":"publisher","first-page":"10363","DOI":"10.1038\/s41598-019-46504-1","volume":"9","author":"E Hishida","year":"2019","unstructured":"Hishida E, Ito H, Komada T, et al. Crucial role of NLRP3 inflammasome in the development of peritoneal dialysis-related peritoneal fibrosis. Sci Rep. 2019;9(1):10363. https:\/\/doi.org\/10.1038\/s41598-019-46504-1.","journal-title":"Sci Rep"},{"key":"2707_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.675363","volume":"8","author":"Q Luo","year":"2021","unstructured":"Luo Q, Hu Q, Zheng Q, et al. Enhanced mPGES-1 contributes to PD-related peritoneal fibrosis via activation of the NLRP3 inflammasome. Front Med (Lausanne). 2021;8: 675363. https:\/\/doi.org\/10.3389\/fmed.2021.675363.","journal-title":"Front Med (Lausanne)"},{"key":"2707_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.790937","volume":"13","author":"MZ Wang","year":"2022","unstructured":"Wang MZ, Wang J, Cao DW, et al. Fucoidan alleviates renal fibrosis in diabetic kidney disease via inhibition of NLRP3 inflammasome-mediated podocyte pyroptosis. Front Pharmacol. 2022;13: 790937. https:\/\/doi.org\/10.3389\/fphar.2022.790937.","journal-title":"Front Pharmacol"},{"key":"2707_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcell.2020.00001","volume":"8","author":"K Zhang","year":"2020","unstructured":"Zhang K, Fan C, Cai D, et al. Contribution of TGF-beta-mediated NLRP3-HMGB1 activation to tubulointerstitial fibrosis in rat with angiotensin ii-induced chronic kidney disease. Front Cell Dev Biol. 2020;8:1. https:\/\/doi.org\/10.3389\/fcell.2020.00001.","journal-title":"Front Cell Dev Biol"},{"key":"2707_CR26","doi-asserted-by":"publisher","first-page":"118454","DOI":"10.1016\/j.lfs.2020.118454","volume":"260","author":"MH Sharawy","year":"2020","unstructured":"Sharawy MH, Serrya MS. Pirfenidone attenuates gentamicin-induced acute kidney injury by inhibiting inflammasome-dependent NLRP3 pathway in rats. Life Sci. 2020;260:118454. https:\/\/doi.org\/10.1016\/j.lfs.2020.118454.","journal-title":"Life Sci"},{"issue":"1","key":"2707_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41419-021-04480-3","volume":"13","author":"BY Nam","year":"2022","unstructured":"Nam BY, Jhee JH, Park J, et al. PGC-1\u03b1 inhibits the NLRP3 inflammasome via preserving mitochondrial viability to protect kidney fibrosis. Cell Death Dis. 2022;13(1):31. https:\/\/doi.org\/10.1038\/s41419-021-04480-3.","journal-title":"Cell Death Dis"},{"key":"2707_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.894981","volume":"13","author":"K Zhang","year":"2022","unstructured":"Zhang K, Lin L, Zhu Y, Zhang N, Zhou M, Li Y. Saikosaponin d alleviates liver fibrosis by negatively regulating the ROS\/NLRP3 inflammasome through activating the ER\u03b2 pathway. Front Pharmacol. 2022;13: 894981. https:\/\/doi.org\/10.3389\/fphar.2022.894981.","journal-title":"Front Pharmacol"},{"issue":"3","key":"2707_CR29","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41419-023-05587-5","volume":"14","author":"J Li","year":"2023","unstructured":"Li J, Lin Q, Shao X, et al. HIF1\u03b1-BNIP3-mediated mitophagy protects against renal fibrosis by decreasing ROS and inhibiting activation of the NLRP3 inflammasome. Cell Death Dis. 2023;14(3):200. https:\/\/doi.org\/10.1038\/s41419-023-05587-5.","journal-title":"Cell Death Dis"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02707-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-025-02707-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02707-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:38:42Z","timestamp":1758789522000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-025-02707-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["2707"],"URL":"https:\/\/doi.org\/10.1007\/s10157-025-02707-7","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"assertion":[{"value":"13 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The animal experiment was approved by the Institutional Animal Care and Use Committee of Hunan Provincial People's Hospital (Approval No. 2020-39).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}